Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Interventional × Absorptiometry, Photon × Clear all

Phase

Phase NA 11 Phase 3 6 Phase 2 5 Phase 1/2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 543 pembrolizumab 425 Paclitaxel 386 Gemcitabine 370 Cisplatin 369 Carboplatin 363 Radiotherapy 326 fludarabine 311 Nivolumab 291 Docetaxel 239 Bevacizumab 238 Irinotecan 211 Magnetic Resonance Spectroscopy 208 Dexamethasone 195 Specimen Handling 192 Fluorouracil 192 Capecitabine 186 Cytarabine 176 Rituximab 175 fludarabine phosphate 170 Oxaliplatin 168 Biopsy 168 Temozolomide 167 Ipilimumab 163 Etoposide 157 Lenalidomide 156 Doxorubicin 147 Cetuximab 147 Leucovorin 144 Bortezomib 144

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02776436 2026-02-17

REDEX

Leiden University Medical Center

Phase 1 Completed

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡